Original contributionDifferentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions
Introduction
Enhancing lesions that arise on routine follow-up brain magnetic resonance imaging (MRI) at the site of a previously identified and treated primary intracranial neoplasm may present a significant diagnostic dilemma. These lesions are typically subjected to radiation and/or chemotherapy and, in most instances, surgical resection. Many do not have specific imaging characteristics that enable the neuroradiologist to discriminate tumor recurrence from inflammatory or necrotic changes that result from treatment with radiation and/or chemotherapy [1]. Both recurrent tumors and treatment-related changes typically demonstrate enhancement with gadolinium. Therefore, often, the clinical course, brain biopsy or imaging over a lengthy follow-up interval is conclusive, not the specific imaging itself [1]. A noninvasive method for an earlier differentiation of recurrent tumor from treatment-related changes, when an abnormal contrast-enhancing lesion is first identified, would be invaluable. Certainly, other imaging MRI techniques, such as proton spectroscopy [2], [3], [4], [5] and MR perfusion [6], offer substantial potential in this regard. Lately, the use of positron emission tomography (PET) imaging especially has shown promising results in differentiating radiation injury from active neoplasm [7], [8]. Diffusion tensor imaging (DTI) is a more complex and complete form of diffusion imaging and has, for example, been able to demonstrate information on white matter tract altered by tumors [9], which can be valuable in presurgical planning, differentiating high-grade gliomas and evaluating the extent of cellular infiltration [10], [11]. In DTI, the directionality of water is probed by the application of diffusion sensitization gradients in multiple directions [12]. An appropriate mathematical combination of directional diffusion-weighted images provides quantitative measures of water diffusion for each voxel via the apparent diffusion coefficient (ADC), as well as the degree of diffusion directionality or anisotropy. In this work, the fractional anisotropy (FA) index was utilized. The tensor can be diagonalized such that only three nonzero elements (λ1, λ2 and λ3) remain along the diagonal. These elements are known as eigenvalues. Each eigenvalue is associated with an eigenvector (ε1, ε2 and ε3), where the largest of the three eigenvalues (λ1) corresponds to the eigenvector ε1 and describes the principal direction of diffusion at that point. Studies using more sophisticated methods for the evaluation of tumors, such as analyses of the role of different eigenvectors, have demonstrated that the value of the major eigenvector of diffusion reflecting diffusivity in the longitudinal direction was significantly lower in the white matter surrounding the glioma than that in the white matter surrounding metastasis, even when the anisotropy showed no difference [13]. Studies like this and other suggest that more sophisticated approaches might yield more information than just mean diffusivity and anisotropy measurements. The incorporation of DTI parameters into a decision rule for differentiating recurrent neoplasms from posttreatment changes represents such an approach. However, prior to the development of a decision rule, we need to understand the distribution of the values of these parameters. Therefore, the purpose of this work is to examine the ability of DTI to differentiate recurrent neoplasms from treatment-related injuries. To that end, we compared standard DTI parameters (ADC and FA values, ADC and FA ratios) and the values and ratios of the eigenvalue indices λ∥ (principal eigenvalue) and λ⊥ (mean of eigenvalues perpendicular to λ∥) in three clinically relevant regions commonly visualized in imaging examinations, namely, in contrast-enhancing lesions, tracts in perilesional edema and tracts in the surrounding normal-appearing white matter (NAWM).
Section snippets
Clinical materials
Approval for this retrospective study was obtained from our Institutional Review Board.
The sample for this retrospective study comprises 28 patients (15 male and 13 female patients) aged 5–56 years (mean=35 years). Each of the patients was included in this retrospective study after presenting with at least one new contrast-enhancing lesion detected on routine follow-up MRI. All patients have previously been diagnosed with an intracranial neoplasm after surgical biopsy (10 patients) or surgical
MRI findings
Conventional MRI T1-weighted postcontrast and T2-weighted images demonstrated a contrast-enhancing lesion surrounded by various degrees of edema in 25 patients. In one patient, the MRI demonstrated more than one contrast-enhancing lesion, all with small surrounding edema.
Based on the clinical and imaging follow-up data and/or histopathology results of contrast-enhancing lesions, the lesions of 14 patients were categorized as tumor recurrence (recurrence group), while the lesions of 12 patients
Discussion
Approximately 18,000 brain tumors are diagnosed annually in the United States [15], which are responsible for significant morbidity and mortality in both the pediatric and the adult populations. Despite the information obtained by conventional MR with contrast-enhanced T1-weighted and T2-weighted sequences in characterizing the location and extent of these tumors, the specification and grading of tumors are still limited. Enhancing lesions that arise on routine follow-up brain MRI at the site
Conclusion
The present study has shown that significant differences in diffusion properties exist between radiation injury changes and recurrent tumor. These differences were mainly found in ADC values and ratios that can be calculated on DWI. Therefore, it can be questioned whether DTI will be a helpful adjunct over DWI to conventional MRI and MRS for the differentiation of these two entities when patients present with new contrast-enhancing lesions at the site of a previously treated brain tumor.
Acknowledgement
This study was supported, in part, by National Institutes of Health grant CA 85878 and by National Institutes of Health/National Cancer Institute grant 1 K07 CA108664 01A1.
References (47)
- et al.
Proton MRS in neurological disorders
Eur Radiol
(1999) - et al.
Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas
Clin Neurol Neurosurg
(2005) - et al.
Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI
J Magn Reson B Series
(1996) - et al.
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations
Med Image Anal
(1997) - et al.
Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings
Int J Radiat Oncol Biol Phys
(1999) - et al.
Diffusion MRI for prediction of response of rectal cancer to chemoradiation
Lancet
(2002) - et al.
Dysmyelination revealed through MR as increased radial (but unchanged axial) diffusion of water
NeuroImage
(2002) - et al.
Diffusion tensor imaging of brain tumors at 3 T: a potential toll for assessing white matter tract invasion?
Clin Radiol
(2003) - et al.
Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy
Neuroradiology
(2002) - et al.
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy
AJNR Am J Neuroradiol
(2001)